Parkinson’s Disease

The organization is making an effort to connect a broader and more diverse set of candidates to clinical trials.

Scheduling therapy sessions every two weeks over six months appears to support long-term functional stability in patients with Parkinson’s disease, researchers say.

The gold standard drug used to treat symptoms of Parkinson’s disease does not appear to have an effect on speech early in the disease course, investigators say.

Patients may begin experiencing a broad range of symptoms — including hearing loss and epilepsy — up to 10 years before a Parkinson’s disease diagnosis, investigators say.

One-year survivors of a heart attack appear to be slightly less likely to develop Parkinson’s disease later in life. That’s according to a new study examining health registries from the Danish National...

Patients with early-stage Parkinson’s disease extended their physical and cognitive abilities with a modest amount of moderate exercise each week, a new study finds.

Properly managed telepsychiatry may ease the challenges of care for nursing home residents with psychosis, and possibly help some facility operators to expand their care offerings, an expert panel says.

The continuation of crucial supports and flexibilities — particularly involving testing and treatments — are key to protecting vulnerable elders in long-term care, the president and CEO of AHCA/NCAL...

Current antibody treatments may not protect against omicron variant, but new drugs are in development … Duodopa improves quality of life in late-stage Parkinson’s disease … CDC pours $22M into fighting...

When compared to alternative options, levodopa provides a superior risk-benefit profile when used to alleviate motor symptoms, and patients are less likely to stop treatment, according to the American...